BioAdaptives Inc
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a … Read more
Market Cap & Net Worth: BioAdaptives Inc (BDPT)
BioAdaptives Inc (PINK:BDPT) has a market capitalization of $1.20 Million ($1.20 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #40129 globally and #13039 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioAdaptives Inc's stock price $0.10 by its total outstanding shares 12008659 (12.01 Million).
BioAdaptives Inc Market Cap History: 2015 to 2025
BioAdaptives Inc's market capitalization history from 2015 to 2025. Data shows change from $1.56 Million to $1.20 Million (-13.64% CAGR).
BioAdaptives Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioAdaptives Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
75.83x
BioAdaptives Inc's market cap is 75.83 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.52 Million | $19.04K | -$171.35K | 132.42x | N/A |
| 2019 | $1.66 Million | $9.93K | -$438.25K | 167.55x | N/A |
| 2020 | $288.21K | $16.33K | -$1.08 Million | 17.65x | N/A |
| 2021 | $120.09K | $19.78K | -$1.05 Million | 6.07x | N/A |
| 2022 | $12.01K | $17.18K | -$896.00K | 0.70x | N/A |
| 2023 | $6.00K | $28.57K | -$712.00K | 0.21x | N/A |
| 2024 | $960.69K | $12.67K | -$899.00K | 75.83x | N/A |
Competitor Companies of BDPT by Market Capitalization
Companies near BioAdaptives Inc in the global market cap rankings as of March 19, 2026.
Key companies related to BioAdaptives Inc by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #54 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $218.85 Billion USD ( CHF200.39 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #435 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #465 globally with a market cap of $45.94 Billion USD ( €44.75 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #54 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $218.85 Billion | CHF77.97 |
| #435 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #465 | Danone SA | PA:BN | $45.94 Billion | €70.78 |
BioAdaptives Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, BioAdaptives Inc's market cap moved from $1.56 Million to $ 1.20 Million, with a yearly change of -13.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.20 Million | +24.88% |
| 2024 | $960.69K | +15900.00% |
| 2023 | $6.00K | -50.00% |
| 2022 | $12.01K | -90.00% |
| 2021 | $120.09K | -58.33% |
| 2020 | $288.21K | -82.68% |
| 2019 | $1.66 Million | -15.54% |
| 2018 | $1.97 Million | -15.85% |
| 2017 | $2.34 Million | -7.14% |
| 2016 | $2.52 Million | +61.54% |
| 2015 | $1.56 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of BioAdaptives Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.20 Million USD |
| MoneyControl | $1.20 Million USD |
| MarketWatch | $1.20 Million USD |
| marketcap.company | $1.20 Million USD |
| Reuters | $1.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.